GW Pharmaceuticals PLC Director/PDMR Shareholding (1855O)

TIDMGWP

RNS Number : 1855O

GW Pharmaceuticals PLC

02 November 2016

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ---------------------------------------------------------------------------- 
 a.   Name                            Mr Justin Gover 
---  ------------------------------  -------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------------------- 
 a.   Position/status                 Chief Executive Officer 
---  ------------------------------  -------------------------------------------- 
 b.   Initial                         Initial notification 
       notification 
       /Amendment 
---  ------------------------------  -------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------------------- 
 a.   Name                            GW Pharmaceuticals PLC 
---  ------------------------------  -------------------------------------------- 
 b.   LEI 
---  ------------------------------  -------------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------------------- 
 a.   Description 
       of the                          Ordinary shares of 0.1p each ISIN: 
       Financial                       GB0030544687 
       instrument,                     Restricted American Depositary 
       type of                         Shares: ISIN: US36197T1372 
       instrument 
       Identification 
       code 
---  ------------------------------  -------------------------------------------- 
 b.   Nature of                      Conversion of 2,513,748 Ordinary 
       the transaction                shares into 209,479 Nasdaq listed 
                                      Restricted ADRs (12 to 1 Conversion 
                                      ratio) 
---  ------------------------------  -------------------------------------------- 
 c.   Price(s)                         Price(s)   Volume(s) 
       and volume(s)                      -         209,479   ADSs issued upon 
                                                               conversion of 
                                                               2,513,748 Ordinary 
                                                               shares 
                                       ---------  ----------  ------------------- 
---  ------------------------------  -------------------------------------------- 
 d.        Aggregated 
            information 
             *    Aggregated volume                n/a 
 
 
             *    Price 
---  ------------------------------  -------------------------------------------- 
 e.   Date of                        2 November 2016 
       the transaction 
---  ------------------------------  -------------------------------------------- 
 f.   Place of                        New York 
       the transaction 
---  ------------------------------  --------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFIDLSLFIIR

(END) Dow Jones Newswires

November 02, 2016 13:05 ET (17:05 GMT)

Gw Pharmaceuticals (LSE:GWP)
過去株価チャート
から 5 2024 まで 6 2024